(Q46128016)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12028215%20AND%20SRC:MED&resulttype=core&format=json

9 November 2019

title

The impact of symptom severity on the cost of Alzheimer's disease (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12028215%20AND%20SRC:MED&resulttype=core&format=json

9 November 2019

0 references

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12028215%20AND%20SRC:MED&resulttype=core&format=json

9 November 2019

author name string

Gary W Small

series ordinal

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12028215%20AND%20SRC:MED&resulttype=core&format=json

9 November 2019

Rachelle L Brooks

series ordinal

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12028215%20AND%20SRC:MED&resulttype=core&format=json

9 November 2019

George Papadopoulos

series ordinal

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12028215%20AND%20SRC:MED&resulttype=core&format=json

9 November 2019

language of work or name

English

0 references

publication date

1 February 2002

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12028215%20AND%20SRC:MED&resulttype=core&format=json

Journal of the American Geriatrics Society

9 November 2019

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12028215%20AND%20SRC:MED&resulttype=core&format=json

9 November 2019

volume

50

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12028215%20AND%20SRC:MED&resulttype=core&format=json

9 November 2019

issue

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12028215%20AND%20SRC:MED&resulttype=core&format=json

9 November 2019

page(s)

321-327

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12028215%20AND%20SRC:MED&resulttype=core&format=json

Chronic care costs in managed care.

9 November 2019

cites work

1 reference

https://api.crossref.org/works/10.1046%2FJ.1532-5415.2002.50065.X

Alzheimer's disease under managed care: implications from Medicare utilization and expenditure patterns

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1532-5415.2002.50065.X

An economic evaluation of donepezil in the treatment of Alzheimer's disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1532-5415.2002.50065.X

Cognitive function and the costs of Alzheimer disease. An exploratory study

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1532-5415.2002.50065.X

The economic burden of Alzheimer's disease care

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1532-5415.2002.50065.X

Alzheimer's disease care: costs and potential savings.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1532-5415.2002.50065.X

Expenditures in caring for patients with dementia who live at home.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1532-5415.2002.50065.X

Economic impact of Alzheimer's disease in the United Kingdom. Cost of care and disease severity for non-institutionalised patients with Alzheimer's disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1532-5415.2002.50065.X

The relationship between donepezil and behavioral disturbances in patients with Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1532-5415.2002.50065.X

Assessment of behavioral problems in dementia: the revised memory and behavior problems checklist

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1532-5415.2002.50065.X

Interrater reliability of the Physical Self-Maintenance Scale and the Instrumental Activities of Daily Living Scale in a variety of health professional representatives.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1532-5415.2002.50065.X

A 5-month, randomized, placebo-controlled trial of galantamine in AD. The Galantamine USA-10 Study Group.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1532-5415.2002.50065.X

Galantamine in AD: A 6-month randomized, placebo-controlled trial with a 6-month extension. The Galantamine USA-1 Study Group.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1532-5415.2002.50065.X

A 12-Item Short-Form Health Survey: construction of scales and preliminary tests of reliability and validity

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1532-5415.2002.50065.X

Proxy response patterns among the aged: effects on estimates of health status and medical care utilization from the 1982-1984 long-term care surveys.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1532-5415.2002.50065.X

The use of proxy respondents in studies of older adults: lessons, challenges, and opportunities

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1532-5415.2002.50065.X

10.1046/J.1532-5415.2002.50065.X

21 January 2018

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12028215%20AND%20SRC:MED&resulttype=core&format=json

9 November 2019

1 reference